Novo submits diabetes pill for ‘priority review’; Top FDA compounding staffer to exit; Roman launches women’s product
Experts discussed artificial intelligence and machine learning at the ePharma Impact conference in New York on Wednesday.
The acquisition represents the U.K. health network’s third in the U.S.
Sanofi begins CEO succession plan; FDA places partial hold on Venclexta cancer trials; One-third of uninsured patients reduce costs by not taking medicine as prescribed.
She has worked at the agency for five years, most recently as chief strategy officer.
Redefining creativity, giving agency leaders more financial freedom and making client services more consultant-like are on the WPP chief’s agenda.
Apple Watch warns 0.5% of users; Amarin’s Vascepa also helps prevent second and third heart attacks; Ohio sues OptumRx for overcharging for drugs.
Amag is offering a chatbot to help women who want to learn about its product for painful sex do so privately.
FDA fast-tracks Purdue opioid-overdose treatment; India tries to block Juul’s entry into the country; Gottlieb calls on industry to adopt modernized clinical-trial approaches.
Healthcare marketers opened up about the subject at MM&M’s PlusOne event in Philadelphia on Thursday.